Rank | Gene Set | Z-score |
---|---|---|
1 | protein neddylation (GO:0045116) | 6.89017154 |
2 | regulation of pigment cell differentiation (GO:0050932) | 6.39997961 |
3 | positive regulation of developmental pigmentation (GO:0048087) | 5.79591548 |
4 | regulation of penile erection (GO:0060405) | 5.59716977 |
5 | negative regulation of heart rate (GO:0010459) | 5.57884693 |
6 | chemosensory behavior (GO:0007635) | 5.52570070 |
7 | short-term memory (GO:0007614) | 5.27652329 |
8 | neuron cell-cell adhesion (GO:0007158) | 5.18971016 |
9 | thrombin receptor signaling pathway (GO:0070493) | 4.94840926 |
10 | vocalization behavior (GO:0071625) | 4.93518181 |
11 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.73522899 |
12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.59801805 |
13 | negative regulation of norepinephrine secretion (GO:0010700) | 4.55076185 |
14 | sequestering of actin monomers (GO:0042989) | 4.48812031 |
15 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.41568348 |
16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38206364 |
17 | protein K6-linked ubiquitination (GO:0085020) | 4.36713512 |
18 | detection of calcium ion (GO:0005513) | 4.35869105 |
19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.34320497 |
20 | synaptic vesicle exocytosis (GO:0016079) | 4.33875552 |
21 | negative regulation of astrocyte differentiation (GO:0048712) | 4.33781238 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.28878318 |
23 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.21369018 |
24 | L-amino acid import (GO:0043092) | 4.21111291 |
25 | regulation of centriole replication (GO:0046599) | 4.10390782 |
26 | behavioral response to ethanol (GO:0048149) | 4.05337441 |
27 | neuron recognition (GO:0008038) | 4.00605177 |
28 | glutamate receptor signaling pathway (GO:0007215) | 3.94218181 |
29 | neuron-neuron synaptic transmission (GO:0007270) | 3.91240108 |
30 | startle response (GO:0001964) | 3.85979471 |
31 | locomotory exploration behavior (GO:0035641) | 3.83152991 |
32 | presynaptic membrane assembly (GO:0097105) | 3.81228537 |
33 | replication fork processing (GO:0031297) | 3.81076041 |
34 | opioid receptor signaling pathway (GO:0038003) | 3.78492289 |
35 | axonal fasciculation (GO:0007413) | 3.78470065 |
36 | synaptic transmission, glutamatergic (GO:0035249) | 3.77254971 |
37 | myelination in peripheral nervous system (GO:0022011) | 3.70966933 |
38 | peripheral nervous system axon ensheathment (GO:0032292) | 3.70966933 |
39 | proline transport (GO:0015824) | 3.70444406 |
40 | dopamine transport (GO:0015872) | 3.69303918 |
41 | glycine transport (GO:0015816) | 3.68230924 |
42 | postsynaptic membrane organization (GO:0001941) | 3.67517013 |
43 | spermatid nucleus differentiation (GO:0007289) | 3.67337458 |
44 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.66002518 |
45 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.66002518 |
46 | positive regulation of fibroblast migration (GO:0010763) | 3.65629776 |
47 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.61025646 |
48 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.60140287 |
49 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57513251 |
50 | exploration behavior (GO:0035640) | 3.57449865 |
51 | synapse assembly (GO:0007416) | 3.55325022 |
52 | negative regulation of cation channel activity (GO:2001258) | 3.55087458 |
53 | L-serine metabolic process (GO:0006563) | 3.54870629 |
54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.54482320 |
55 | mitochondrial genome maintenance (GO:0000002) | 3.54196253 |
56 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52721249 |
57 | glutamate secretion (GO:0014047) | 3.52053259 |
58 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.49044501 |
59 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.49044501 |
60 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.47448562 |
61 | protein localization to synapse (GO:0035418) | 3.46974618 |
62 | neurotransmitter secretion (GO:0007269) | 3.46370317 |
63 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.44060028 |
64 | neurotransmitter transport (GO:0006836) | 3.43959275 |
65 | righting reflex (GO:0060013) | 3.43742139 |
66 | mitotic metaphase plate congression (GO:0007080) | 3.41051209 |
67 | response to histamine (GO:0034776) | 3.37526382 |
68 | adenosine receptor signaling pathway (GO:0001973) | 3.36193851 |
69 | regulation of sensory perception (GO:0051931) | 3.35993947 |
70 | regulation of sensory perception of pain (GO:0051930) | 3.35993947 |
71 | neuronal action potential propagation (GO:0019227) | 3.35938542 |
72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.33940020 |
73 | negative regulation of neurotransmitter transport (GO:0051589) | 3.33111667 |
74 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32570787 |
75 | inner ear receptor cell development (GO:0060119) | 3.32027005 |
76 | negative regulation of heart contraction (GO:0045822) | 3.30395843 |
77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.29585205 |
78 | regulation of synaptic vesicle transport (GO:1902803) | 3.27376004 |
79 | epithelial cilium movement (GO:0003351) | 3.25335399 |
80 | mitotic G2/M transition checkpoint (GO:0044818) | 3.25045019 |
81 | regulation of integrin activation (GO:0033623) | 3.23722534 |
82 | presynaptic membrane organization (GO:0097090) | 3.23719417 |
83 | regulation of mitotic spindle organization (GO:0060236) | 3.23371350 |
84 | microtubule depolymerization (GO:0007019) | 3.22756280 |
85 | regulation of spindle organization (GO:0090224) | 3.22464299 |
86 | reflex (GO:0060004) | 3.22463268 |
87 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21710141 |
88 | dendritic spine morphogenesis (GO:0060997) | 3.21473215 |
89 | regulation of appetite (GO:0032098) | 3.20377148 |
90 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.19939687 |
91 | regulation of synapse maturation (GO:0090128) | 3.19611991 |
92 | DNA strand renaturation (GO:0000733) | 3.18050145 |
93 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.16992578 |
94 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.12973501 |
95 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.11425636 |
96 | amino acid import (GO:0043090) | 3.10259232 |
97 | behavioral response to cocaine (GO:0048148) | 3.10090756 |
98 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.09114725 |
99 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.08442095 |
100 | bone trabecula formation (GO:0060346) | 3.08173017 |
101 | glycosphingolipid biosynthetic process (GO:0006688) | 3.07967603 |
102 | transmission of nerve impulse (GO:0019226) | 3.07421132 |
103 | catecholamine transport (GO:0051937) | 3.07009887 |
104 | regulation of vesicle fusion (GO:0031338) | 3.06927253 |
105 | dendrite development (GO:0016358) | 3.06053601 |
106 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.05204938 |
107 | regulation of neurotransmitter levels (GO:0001505) | 3.04522982 |
108 | kinetochore assembly (GO:0051382) | 3.03153840 |
109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.02010787 |
110 | polyketide metabolic process (GO:0030638) | 3.00548582 |
111 | doxorubicin metabolic process (GO:0044598) | 3.00548582 |
112 | daunorubicin metabolic process (GO:0044597) | 3.00548582 |
113 | synaptic transmission, dopaminergic (GO:0001963) | 3.00056810 |
114 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.96891851 |
115 | fear response (GO:0042596) | 2.96253113 |
116 | single strand break repair (GO:0000012) | 2.96017192 |
117 | long-term synaptic potentiation (GO:0060291) | 2.95746621 |
118 | adult walking behavior (GO:0007628) | 2.95220842 |
119 | synaptic vesicle endocytosis (GO:0048488) | 2.94992435 |
120 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.93174509 |
121 | neurotransmitter catabolic process (GO:0042135) | 2.90708554 |
122 | fibroblast migration (GO:0010761) | 2.90654869 |
123 | dentate gyrus development (GO:0021542) | 2.90337303 |
124 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90248167 |
125 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89917248 |
126 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.89859802 |
127 | metaphase plate congression (GO:0051310) | 2.89751900 |
128 | synaptic vesicle maturation (GO:0016188) | 2.89621579 |
129 | inner ear receptor stereocilium organization (GO:0060122) | 2.88642533 |
130 | regulation of neurological system process (GO:0031644) | 2.87878083 |
131 | positive regulation of synapse assembly (GO:0051965) | 2.87747617 |
132 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86917592 |
133 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.85403822 |
134 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85136658 |
135 | limb development (GO:0060173) | 2.84389015 |
136 | appendage development (GO:0048736) | 2.84389015 |
137 | superoxide anion generation (GO:0042554) | 2.83999665 |
138 | regulation of postsynaptic membrane potential (GO:0060078) | 2.83216290 |
139 | response to parathyroid hormone (GO:0071107) | 2.83131029 |
140 | developmental pigmentation (GO:0048066) | 2.82584691 |
141 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82167152 |
142 | response to auditory stimulus (GO:0010996) | 2.81915677 |
143 | neurotransmitter biosynthetic process (GO:0042136) | 2.80597368 |
144 | platelet dense granule organization (GO:0060155) | 2.77790531 |
145 | synapse organization (GO:0050808) | 2.76902261 |
146 | regulation of dopamine metabolic process (GO:0042053) | 2.74769533 |
147 | regulation of catecholamine metabolic process (GO:0042069) | 2.74769533 |
148 | long-term memory (GO:0007616) | 2.73515202 |
149 | auditory receptor cell stereocilium organization (GO:0060088) | 2.73426498 |
150 | negative regulation of catecholamine secretion (GO:0033604) | 2.73266213 |
151 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.71915815 |
152 | synaptic transmission (GO:0007268) | 2.71905942 |
153 | neuronal ion channel clustering (GO:0045161) | 2.71466097 |
154 | cGMP biosynthetic process (GO:0006182) | 2.70527501 |
155 | chromatin remodeling at centromere (GO:0031055) | 2.70510308 |
156 | positive regulation of catenin import into nucleus (GO:0035413) | 2.70340617 |
157 | CENP-A containing nucleosome assembly (GO:0034080) | 2.68820133 |
158 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.68803929 |
159 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.67828435 |
160 | regulation of platelet aggregation (GO:0090330) | 2.67554535 |
161 | regulation of neurotransmitter secretion (GO:0046928) | 2.67410408 |
162 | regulation of neurotransmitter transport (GO:0051588) | 2.66470325 |
163 | DNA double-strand break processing (GO:0000729) | 2.66284243 |
164 | behavioral defense response (GO:0002209) | 2.63236433 |
165 | behavioral fear response (GO:0001662) | 2.63236433 |
166 | G2 DNA damage checkpoint (GO:0031572) | 2.62853919 |
167 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.62199277 |
168 | negative regulation of platelet activation (GO:0010544) | 2.62183661 |
169 | cilium movement (GO:0003341) | 2.61914845 |
170 | mating behavior (GO:0007617) | 2.60645888 |
171 | membrane depolarization (GO:0051899) | 2.60612572 |
172 | regulation of synapse assembly (GO:0051963) | 2.60443121 |
173 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.60397393 |
174 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.60277194 |
175 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.59527943 |
176 | prepulse inhibition (GO:0060134) | 2.59516000 |
177 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.59221348 |
178 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58875761 |
179 | regulation of developmental pigmentation (GO:0048070) | 2.58543551 |
180 | phagosome maturation (GO:0090382) | 2.58446883 |
181 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.58416078 |
182 | gamma-aminobutyric acid transport (GO:0015812) | 2.58085019 |
183 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.57451591 |
184 | regulation of neurotransmitter uptake (GO:0051580) | 2.57050891 |
185 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.55653079 |
186 | cGMP metabolic process (GO:0046068) | 2.55510814 |
187 | negative regulation of blood circulation (GO:1903523) | 2.54539179 |
188 | cardiolipin metabolic process (GO:0032048) | 2.52662682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.73236805 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.56629254 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.04756188 |
4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.32973467 |
5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.89493896 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76717454 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66516076 |
8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.64962795 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62294431 |
10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51040391 |
11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45019856 |
12 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.44739070 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41703167 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30430266 |
15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28886156 |
16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28886156 |
17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19859902 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17379736 |
19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13560008 |
20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.04241761 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03634902 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.01402745 |
23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.01354406 |
24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99824179 |
25 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98492625 |
26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98052321 |
27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97153576 |
28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.94660451 |
29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93855038 |
30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91634816 |
31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.90957573 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88561977 |
33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86070886 |
34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85684260 |
35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84565869 |
36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84392127 |
37 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83790199 |
38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83004784 |
39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.81174306 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80562956 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80099577 |
42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.79693788 |
43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79556800 |
44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78457207 |
45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75687751 |
46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71877650 |
47 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70332504 |
48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67816308 |
49 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.66284536 |
50 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.65995120 |
51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63170244 |
52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62973047 |
53 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.60027688 |
54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.59529617 |
55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.59097041 |
56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.58855225 |
57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55601927 |
58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.54655310 |
59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53584073 |
60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51017391 |
61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.48916694 |
62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48768232 |
63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47778864 |
64 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.47538136 |
65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.46925903 |
66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46176325 |
67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45862832 |
68 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45819548 |
69 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.44206285 |
70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.44177015 |
71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43798582 |
72 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.42883686 |
73 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42305681 |
74 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.41095662 |
75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40316760 |
76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40206878 |
77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39890217 |
78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39731744 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39119873 |
80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37455267 |
81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37079889 |
82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35006599 |
83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.33845948 |
84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33701783 |
85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33646762 |
86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33221604 |
87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32510862 |
88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31601131 |
89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31453157 |
90 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30809136 |
91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30669081 |
92 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30071286 |
93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28925473 |
94 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28803145 |
95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27977710 |
96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27508660 |
97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26648695 |
98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26508916 |
99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26368644 |
100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26142249 |
101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26138720 |
102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25739582 |
103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25450989 |
104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23662099 |
105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23097451 |
106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.22952947 |
107 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.22392484 |
108 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21893537 |
109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21563150 |
110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20847351 |
111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.20664854 |
112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17991993 |
113 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17728961 |
114 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17424698 |
115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16523287 |
116 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.16355197 |
117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15121694 |
118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14722634 |
119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14605161 |
120 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.13819735 |
121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12165143 |
122 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11720008 |
123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11563322 |
124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11563322 |
125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11196801 |
126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.11000295 |
127 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10963711 |
128 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.09549045 |
129 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09434625 |
130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09344441 |
131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09344441 |
132 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08921413 |
133 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08865565 |
134 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08767000 |
135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08597170 |
136 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.08261764 |
137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07991366 |
138 | JUN_21703547_ChIP-Seq_K562_Human | 1.06536892 |
139 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05554801 |
140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04771534 |
141 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00608401 |
142 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00560426 |
143 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.98701439 |
144 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97389637 |
145 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97389637 |
146 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95304754 |
147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94919598 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003136_yellow_coat_color | 7.83326815 |
2 | MP0003880_abnormal_central_pattern | 5.11322144 |
3 | MP0004859_abnormal_synaptic_plasticity | 4.29588073 |
4 | MP0010030_abnormal_orbit_morphology | 4.07900169 |
5 | MP0000372_irregular_coat_pigmentation | 3.68889015 |
6 | MP0002938_white_spotting | 3.47389908 |
7 | MP0003011_delayed_dark_adaptation | 3.41379821 |
8 | MP0003635_abnormal_synaptic_transmissio | 3.34677215 |
9 | MP0009745_abnormal_behavioral_response | 3.24975491 |
10 | MP0005248_abnormal_Harderian_gland | 3.22648420 |
11 | MP0001968_abnormal_touch/_nociception | 3.12977744 |
12 | MP0006276_abnormal_autonomic_nervous | 3.03418157 |
13 | MP0001486_abnormal_startle_reflex | 2.93455408 |
14 | MP0009046_muscle_twitch | 2.92689090 |
15 | MP0002736_abnormal_nociception_after | 2.91803688 |
16 | MP0002064_seizures | 2.88678524 |
17 | MP0005464_abnormal_platelet_physiology | 2.86243749 |
18 | MP0001501_abnormal_sleep_pattern | 2.76536969 |
19 | MP0005645_abnormal_hypothalamus_physiol | 2.74165159 |
20 | MP0001188_hyperpigmentation | 2.70230246 |
21 | MP0001529_abnormal_vocalization | 2.68312343 |
22 | MP0002063_abnormal_learning/memory/cond | 2.65230643 |
23 | MP0002572_abnormal_emotion/affect_behav | 2.63106966 |
24 | MP0001440_abnormal_grooming_behavior | 2.49433745 |
25 | MP0002102_abnormal_ear_morphology | 2.44932161 |
26 | MP0003122_maternal_imprinting | 2.41788977 |
27 | MP0002272_abnormal_nervous_system | 2.39620624 |
28 | MP0004142_abnormal_muscle_tone | 2.27221653 |
29 | MP0002735_abnormal_chemical_nociception | 2.25912830 |
30 | MP0005670_abnormal_white_adipose | 2.24445420 |
31 | MP0002067_abnormal_sensory_capabilities | 2.19221417 |
32 | MP0002653_abnormal_ependyma_morphology | 2.15347666 |
33 | MP0005423_abnormal_somatic_nervous | 2.12289173 |
34 | MP0005174_abnormal_tail_pigmentation | 2.03555623 |
35 | MP0002876_abnormal_thyroid_physiology | 2.00038226 |
36 | MP0005386_behavior/neurological_phenoty | 1.96213068 |
37 | MP0004924_abnormal_behavior | 1.96213068 |
38 | MP0005646_abnormal_pituitary_gland | 1.92733030 |
39 | MP0002184_abnormal_innervation | 1.89963573 |
40 | MP0004742_abnormal_vestibular_system | 1.88259840 |
41 | MP0002557_abnormal_social/conspecific_i | 1.88197302 |
42 | MP0002734_abnormal_mechanical_nocicepti | 1.81742212 |
43 | MP0000778_abnormal_nervous_system | 1.81200087 |
44 | MP0002095_abnormal_skin_pigmentation | 1.80506467 |
45 | MP0003787_abnormal_imprinting | 1.72474088 |
46 | MP0008058_abnormal_DNA_repair | 1.67605954 |
47 | MP0001879_abnormal_lymphatic_vessel | 1.66760160 |
48 | MP0004381_abnormal_hair_follicle | 1.65149865 |
49 | MP0001970_abnormal_pain_threshold | 1.63353083 |
50 | MP0001905_abnormal_dopamine_level | 1.62769088 |
51 | MP0002733_abnormal_thermal_nociception | 1.59998787 |
52 | MP0003879_abnormal_hair_cell | 1.59443983 |
53 | MP0001502_abnormal_circadian_rhythm | 1.56986202 |
54 | MP0004270_analgesia | 1.53612992 |
55 | MP0005084_abnormal_gallbladder_morpholo | 1.48805785 |
56 | MP0008961_abnormal_basal_metabolism | 1.36728484 |
57 | MP0003718_maternal_effect | 1.34915687 |
58 | MP0000569_abnormal_digit_pigmentation | 1.33995989 |
59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.33103042 |
60 | MP0002837_dystrophic_cardiac_calcinosis | 1.32130302 |
61 | MP0002822_catalepsy | 1.32015315 |
62 | MP0000534_abnormal_ureter_morphology | 1.31229706 |
63 | MP0000955_abnormal_spinal_cord | 1.28455961 |
64 | MP0004215_abnormal_myocardial_fiber | 1.27877527 |
65 | MP0002751_abnormal_autonomic_nervous | 1.27315796 |
66 | MP0006054_spinal_hemorrhage | 1.25606607 |
67 | MP0001963_abnormal_hearing_physiology | 1.25522583 |
68 | MP0004858_abnormal_nervous_system | 1.25328181 |
69 | MP0003121_genomic_imprinting | 1.23073987 |
70 | MP0002066_abnormal_motor_capabilities/c | 1.22137705 |
71 | MP0008775_abnormal_heart_ventricle | 1.19907785 |
72 | MP0008872_abnormal_physiological_respon | 1.19580750 |
73 | MP0003937_abnormal_limbs/digits/tail_de | 1.19486154 |
74 | MP0002882_abnormal_neuron_morphology | 1.17357752 |
75 | MP0003950_abnormal_plasma_membrane | 1.11415375 |
76 | MP0000566_synostosis | 1.08830548 |
77 | MP0001661_extended_life_span | 1.08537036 |
78 | MP0001485_abnormal_pinna_reflex | 1.06716601 |
79 | MP0003119_abnormal_digestive_system | 1.06214169 |
80 | MP0005171_absent_coat_pigmentation | 1.05503520 |
81 | MP0008569_lethality_at_weaning | 1.05487347 |
82 | MP0004811_abnormal_neuron_physiology | 1.05487297 |
83 | MP0005535_abnormal_body_temperature | 1.05330625 |
84 | MP0002233_abnormal_nose_morphology | 1.04475229 |
85 | MP0001984_abnormal_olfaction | 1.04452663 |
86 | MP0000026_abnormal_inner_ear | 1.03903700 |
87 | MP0005083_abnormal_biliary_tract | 1.03046125 |
88 | MP0003938_abnormal_ear_development | 1.02728657 |
89 | MP0000230_abnormal_systemic_arterial | 1.02432539 |
90 | MP0005551_abnormal_eye_electrophysiolog | 1.01725609 |
91 | MP0009765_abnormal_xenobiotic_induced | 1.01339275 |
92 | MP0002697_abnormal_eye_size | 1.01233150 |
93 | MP0000631_abnormal_neuroendocrine_gland | 0.99930684 |
94 | MP0005623_abnormal_meninges_morphology | 0.98555044 |
95 | MP0003111_abnormal_nucleus_morphology | 0.98444563 |
96 | MP0002069_abnormal_eating/drinking_beha | 0.96801692 |
97 | MP0006292_abnormal_olfactory_placode | 0.96695615 |
98 | MP0005075_abnormal_melanosome_morpholog | 0.95286012 |
99 | MP0009780_abnormal_chondrocyte_physiolo | 0.91914896 |
100 | MP0002163_abnormal_gland_morphology | 0.91473067 |
101 | MP0005409_darkened_coat_color | 0.88462553 |
102 | MP0006072_abnormal_retinal_apoptosis | 0.87747784 |
103 | MP0000678_abnormal_parathyroid_gland | 0.87703474 |
104 | MP0001664_abnormal_digestion | 0.87527231 |
105 | MP0005379_endocrine/exocrine_gland_phen | 0.86554084 |
106 | MP0002752_abnormal_somatic_nervous | 0.86324158 |
107 | MP0001986_abnormal_taste_sensitivity | 0.85318035 |
108 | MP0008004_abnormal_stomach_pH | 0.84834964 |
109 | MP0004133_heterotaxia | 0.84114706 |
110 | MP0000427_abnormal_hair_cycle | 0.82569625 |
111 | MP0004484_altered_response_of | 0.81870410 |
112 | MP0003633_abnormal_nervous_system | 0.80859283 |
113 | MP0009764_decreased_sensitivity_to | 0.80238259 |
114 | MP0002295_abnormal_pulmonary_circulatio | 0.79266989 |
115 | MP0002090_abnormal_vision | 0.78983519 |
116 | MP0002277_abnormal_respiratory_mucosa | 0.78310700 |
117 | MP0001177_atelectasis | 0.77997742 |
118 | MP0002152_abnormal_brain_morphology | 0.76291158 |
119 | MP0003186_abnormal_redox_activity | 0.76240180 |
120 | MP0008874_decreased_physiological_sensi | 0.75152351 |
121 | MP0003077_abnormal_cell_cycle | 0.74788291 |
122 | MP0003638_abnormal_response/metabolism_ | 0.73991549 |
123 | MP0001286_abnormal_eye_development | 0.73757361 |
124 | MP0003631_nervous_system_phenotype | 0.73544495 |
125 | MP0005410_abnormal_fertilization | 0.72419707 |
126 | MP0004036_abnormal_muscle_relaxation | 0.72003652 |
127 | MP0010386_abnormal_urinary_bladder | 0.71699380 |
128 | MP0003195_calcinosis | 0.71598922 |
129 | MP0003690_abnormal_glial_cell | 0.70068555 |
130 | MP0002909_abnormal_adrenal_gland | 0.69758890 |
131 | MP0005377_hearing/vestibular/ear_phenot | 0.68108860 |
132 | MP0003878_abnormal_ear_physiology | 0.68108860 |
133 | MP0002075_abnormal_coat/hair_pigmentati | 0.67463185 |
134 | MP0005266_abnormal_metabolism | 0.66223291 |
135 | MP0005620_abnormal_muscle_contractility | 0.65309453 |
136 | MP0004883_abnormal_blood_vessel | 0.65081218 |
137 | MP0004510_myositis | 0.64716926 |
138 | MP0003861_abnormal_nervous_system | 0.64140057 |
139 | MP0005595_abnormal_vascular_smooth | 0.63895813 |
140 | MP0002111_abnormal_tail_morphology | 0.63708691 |
141 | MP0005253_abnormal_eye_physiology | 0.63276699 |
142 | MP0001346_abnormal_lacrimal_gland | 0.62893961 |
143 | MP0004084_abnormal_cardiac_muscle | 0.62884533 |
144 | MP0002932_abnormal_joint_morphology | 0.62444223 |
145 | MP0009697_abnormal_copulation | 0.62199317 |
146 | MP0002229_neurodegeneration | 0.60729553 |
147 | MP0002282_abnormal_trachea_morphology | 0.60450077 |
148 | MP0005499_abnormal_olfactory_system | 0.60276853 |
149 | MP0005394_taste/olfaction_phenotype | 0.60276853 |
150 | MP0004085_abnormal_heartbeat | 0.59265035 |
151 | MP0008932_abnormal_embryonic_tissue | 0.59171301 |
152 | MP0001293_anophthalmia | 0.59027221 |
153 | MP0003646_muscle_fatigue | 0.58695120 |
154 | MP0005395_other_phenotype | 0.57434043 |
155 | MP0005195_abnormal_posterior_eye | 0.57009970 |
156 | MP0003942_abnormal_urinary_system | 0.55902253 |
157 | MP0004885_abnormal_endolymph | 0.54285772 |
158 | MP0003075_altered_response_to | 0.52837559 |
159 | MP0010094_abnormal_chromosome_stability | 0.50897418 |
160 | MP0009379_abnormal_foot_pigmentation | 0.50782721 |
161 | MP0005310_abnormal_salivary_gland | 0.50770662 |
162 | MP0009250_abnormal_appendicular_skeleto | 0.50751887 |
163 | MP0003632_abnormal_nervous_system | 0.50086268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.47751239 |
2 | Oligodactyly (hands) (HP:0001180) | 4.76263107 |
3 | Increased mean platelet volume (HP:0011877) | 4.73833648 |
4 | Febrile seizures (HP:0002373) | 4.67343143 |
5 | Focal seizures (HP:0007359) | 4.59054805 |
6 | Prolonged bleeding time (HP:0003010) | 4.46709624 |
7 | Menorrhagia (HP:0000132) | 4.29244884 |
8 | Split foot (HP:0001839) | 4.19805608 |
9 | Abnormal platelet volume (HP:0011876) | 4.17983956 |
10 | Petechiae (HP:0000967) | 3.93626032 |
11 | Epileptic encephalopathy (HP:0200134) | 3.91840458 |
12 | Atonic seizures (HP:0010819) | 3.85797753 |
13 | Severe visual impairment (HP:0001141) | 3.83085553 |
14 | Pancreatic cysts (HP:0001737) | 3.82222767 |
15 | Limb dystonia (HP:0002451) | 3.76686728 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 3.72305741 |
17 | True hermaphroditism (HP:0010459) | 3.66407707 |
18 | Anencephaly (HP:0002323) | 3.62536645 |
19 | Hyperventilation (HP:0002883) | 3.59199791 |
20 | Purpura (HP:0000979) | 3.56014893 |
21 | Poikilocytosis (HP:0004447) | 3.52080210 |
22 | Pancreatic fibrosis (HP:0100732) | 3.50415671 |
23 | Agitation (HP:0000713) | 3.41181071 |
24 | Visual hallucinations (HP:0002367) | 3.40699150 |
25 | Abnormal hair whorl (HP:0010721) | 3.32578896 |
26 | Gingival bleeding (HP:0000225) | 3.29967976 |
27 | Progressive cerebellar ataxia (HP:0002073) | 3.29488040 |
28 | Anophthalmia (HP:0000528) | 3.25337608 |
29 | Myokymia (HP:0002411) | 3.22884222 |
30 | Oligodactyly (HP:0012165) | 3.18989854 |
31 | Protruding tongue (HP:0010808) | 3.14960321 |
32 | Partial duplication of the phalanx of hand (HP:0009999) | 3.13654698 |
33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.06388211 |
34 | Thyroid-stimulating hormone excess (HP:0002925) | 3.05245338 |
35 | Broad-based gait (HP:0002136) | 3.00788304 |
36 | Absence seizures (HP:0002121) | 3.00540366 |
37 | Fetal akinesia sequence (HP:0001989) | 2.99124582 |
38 | Dialeptic seizures (HP:0011146) | 2.98317081 |
39 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.95823967 |
40 | Abnormal lung lobation (HP:0002101) | 2.93281798 |
41 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.86082052 |
42 | Parakeratosis (HP:0001036) | 2.82416758 |
43 | Polyphagia (HP:0002591) | 2.80551741 |
44 | Drooling (HP:0002307) | 2.79641839 |
45 | Excessive salivation (HP:0003781) | 2.79641839 |
46 | Fair hair (HP:0002286) | 2.79330756 |
47 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.72847901 |
48 | Inappropriate behavior (HP:0000719) | 2.71344552 |
49 | Epistaxis (HP:0000421) | 2.69987897 |
50 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.68399452 |
51 | Abnormality of alanine metabolism (HP:0010916) | 2.68399452 |
52 | Hyperalaninemia (HP:0003348) | 2.68399452 |
53 | Exotropia (HP:0000577) | 2.68006865 |
54 | Absent thumb (HP:0009777) | 2.64201456 |
55 | Gaze-evoked nystagmus (HP:0000640) | 2.63274182 |
56 | Absent hand (HP:0004050) | 2.62486854 |
57 | Mutism (HP:0002300) | 2.61174905 |
58 | Anxiety (HP:0000739) | 2.59449380 |
59 | Failure to thrive in infancy (HP:0001531) | 2.58227572 |
60 | Generalized hypopigmentation of hair (HP:0011358) | 2.57460485 |
61 | 11 pairs of ribs (HP:0000878) | 2.56018140 |
62 | Partial duplication of thumb phalanx (HP:0009944) | 2.55495293 |
63 | Generalized myoclonic seizures (HP:0002123) | 2.51366374 |
64 | Upper limb muscle weakness (HP:0003484) | 2.48680208 |
65 | Hyperphosphatemia (HP:0002905) | 2.48235864 |
66 | Cystic liver disease (HP:0006706) | 2.47725718 |
67 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.47372387 |
68 | Annular pancreas (HP:0001734) | 2.46319158 |
69 | Esotropia (HP:0000565) | 2.44803664 |
70 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.43380920 |
71 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.43380920 |
72 | Reticulocytopenia (HP:0001896) | 2.42111983 |
73 | Akinesia (HP:0002304) | 2.41888079 |
74 | Abnormality of macular pigmentation (HP:0008002) | 2.41373871 |
75 | Poor suck (HP:0002033) | 2.39768540 |
76 | Depression (HP:0000716) | 2.38496366 |
77 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.34902200 |
78 | Broad foot (HP:0001769) | 2.34621193 |
79 | Occipital encephalocele (HP:0002085) | 2.33572825 |
80 | Abnormality of the parietal bone (HP:0002696) | 2.32339854 |
81 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32283835 |
82 | Absent/shortened dynein arms (HP:0200106) | 2.32283835 |
83 | Cortical dysplasia (HP:0002539) | 2.32223523 |
84 | Absent epiphyses (HP:0010577) | 2.31843157 |
85 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.31843157 |
86 | Gait imbalance (HP:0002141) | 2.30884367 |
87 | Septo-optic dysplasia (HP:0100842) | 2.28673545 |
88 | Ectopic kidney (HP:0000086) | 2.28309362 |
89 | Horizontal nystagmus (HP:0000666) | 2.28204189 |
90 | Medial flaring of the eyebrow (HP:0010747) | 2.27810368 |
91 | Abnormal auditory evoked potentials (HP:0006958) | 2.25250427 |
92 | Irregular epiphyses (HP:0010582) | 2.23065614 |
93 | Abnormal platelet function (HP:0011869) | 2.22979224 |
94 | Impaired platelet aggregation (HP:0003540) | 2.22979224 |
95 | Abnormal ciliary motility (HP:0012262) | 2.22581843 |
96 | Small intestinal stenosis (HP:0012848) | 2.22434436 |
97 | Duodenal stenosis (HP:0100867) | 2.22434436 |
98 | Poor eye contact (HP:0000817) | 2.22181978 |
99 | Congenital sensorineural hearing impairment (HP:0008527) | 2.20942035 |
100 | Increased IgM level (HP:0003496) | 2.20385541 |
101 | Abnormality of salivation (HP:0100755) | 2.17501641 |
102 | Abnormality of incisor morphology (HP:0011063) | 2.17366362 |
103 | Absent speech (HP:0001344) | 2.16973284 |
104 | Abnormal eating behavior (HP:0100738) | 2.15702641 |
105 | Male pseudohermaphroditism (HP:0000037) | 2.15656210 |
106 | Sloping forehead (HP:0000340) | 2.15620504 |
107 | Sclerocornea (HP:0000647) | 2.14387562 |
108 | Incomplete penetrance (HP:0003829) | 2.13984689 |
109 | Blue irides (HP:0000635) | 2.11380427 |
110 | Small hand (HP:0200055) | 2.11330685 |
111 | Stenosis of the external auditory canal (HP:0000402) | 2.10444352 |
112 | Epileptiform EEG discharges (HP:0011182) | 2.09262930 |
113 | Hypoplasia of the radius (HP:0002984) | 2.09237988 |
114 | Short tibia (HP:0005736) | 2.07641999 |
115 | Hypoplastic pelvis (HP:0008839) | 2.07625909 |
116 | Optic nerve hypoplasia (HP:0000609) | 2.03262532 |
117 | Tetany (HP:0001281) | 2.03061521 |
118 | Acanthocytosis (HP:0001927) | 2.02789084 |
119 | Disproportionate short-trunk short stature (HP:0003521) | 2.01309011 |
120 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00587828 |
121 | Colon cancer (HP:0003003) | 1.98177692 |
122 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97550563 |
123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97550563 |
124 | Coronal craniosynostosis (HP:0004440) | 1.97225535 |
125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.97068133 |
126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.95447191 |
127 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94708199 |
128 | Congenital primary aphakia (HP:0007707) | 1.94634240 |
129 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94630409 |
130 | Supranuclear gaze palsy (HP:0000605) | 1.93489520 |
131 | Hypoplasia of the pons (HP:0012110) | 1.92790221 |
132 | Decreased testicular size (HP:0008734) | 1.92600507 |
133 | Narrow nasal bridge (HP:0000446) | 1.92471416 |
134 | Esophageal atresia (HP:0002032) | 1.89647762 |
135 | Hemiparesis (HP:0001269) | 1.89100931 |
136 | Missing ribs (HP:0000921) | 1.88761544 |
137 | Widely spaced teeth (HP:0000687) | 1.88468622 |
138 | Abnormality of the duodenum (HP:0002246) | 1.88115145 |
139 | Bicornuate uterus (HP:0000813) | 1.86976976 |
140 | Psychosis (HP:0000709) | 1.86795496 |
141 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86447461 |
142 | Intellectual disability, moderate (HP:0002342) | 1.86151999 |
143 | Increased circulating renin level (HP:0000848) | 1.86096686 |
144 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85911830 |
145 | Nephronophthisis (HP:0000090) | 1.85841359 |
146 | Abnormality of the corticospinal tract (HP:0002492) | 1.85812127 |
147 | Hypsarrhythmia (HP:0002521) | 1.85246003 |
148 | Cone-rod dystrophy (HP:0000548) | 1.84592110 |
149 | Inability to walk (HP:0002540) | 1.84587242 |
150 | Broad nasal tip (HP:0000455) | 1.84092857 |
151 | Congenital hepatic fibrosis (HP:0002612) | 1.83472181 |
152 | Triphalangeal thumb (HP:0001199) | 1.83008627 |
153 | Long clavicles (HP:0000890) | 1.82988604 |
154 | Postural instability (HP:0002172) | 1.81766514 |
155 | Thrombocytosis (HP:0001894) | 1.81571146 |
156 | Abnormal pancreas size (HP:0012094) | 1.81487654 |
157 | Pheochromocytoma (HP:0002666) | 1.81430618 |
158 | Abnormality of the pons (HP:0007361) | 1.81414493 |
159 | Truncal ataxia (HP:0002078) | 1.81303123 |
160 | Conical tooth (HP:0000698) | 1.81242093 |
161 | Conjunctival telangiectasia (HP:0000524) | 1.81120777 |
162 | Alveolar cell carcinoma (HP:0006519) | 1.79493313 |
163 | Genital tract atresia (HP:0001827) | 1.79426693 |
164 | Amblyopia (HP:0000646) | 1.78441778 |
165 | Dysmetria (HP:0001310) | 1.78076398 |
166 | Lissencephaly (HP:0001339) | 1.77839740 |
167 | Vaginal atresia (HP:0000148) | 1.77173161 |
168 | Torticollis (HP:0000473) | 1.76254385 |
169 | Ankle clonus (HP:0011448) | 1.75983820 |
170 | Hypoplastic iliac wings (HP:0002866) | 1.75949823 |
171 | Hip dysplasia (HP:0001385) | 1.75310731 |
172 | Severe Myopia (HP:0011003) | 1.75180757 |
173 | Chronic hepatic failure (HP:0100626) | 1.74953296 |
174 | Generalized aminoaciduria (HP:0002909) | 1.74638137 |
175 | Progressive inability to walk (HP:0002505) | 1.74547504 |
176 | Mild short stature (HP:0003502) | 1.73306240 |
177 | Hypothermia (HP:0002045) | 1.73097181 |
178 | Abnormal social behavior (HP:0012433) | 1.72605850 |
179 | Impaired social interactions (HP:0000735) | 1.72605850 |
180 | Coarctation of aorta (HP:0001680) | 1.71944242 |
181 | Synostosis involving the elbow (HP:0003938) | 1.71759559 |
182 | Humeroradial synostosis (HP:0003041) | 1.71759559 |
183 | Hypoventilation (HP:0002791) | 1.71444003 |
184 | Preaxial hand polydactyly (HP:0001177) | 1.70466802 |
185 | Abnormality of binocular vision (HP:0011514) | 1.69855535 |
186 | Diplopia (HP:0000651) | 1.69855535 |
187 | Large earlobe (HP:0009748) | 1.68991361 |
188 | Dysdiadochokinesis (HP:0002075) | 1.65587991 |
189 | Aplasia cutis congenita (HP:0001057) | 1.64048820 |
190 | Abnormality of dental color (HP:0011073) | 1.63546009 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 5.93769733 |
2 | NTRK3 | 4.08732206 |
3 | CASK | 3.86658502 |
4 | MAP3K12 | 3.65028052 |
5 | EPHB2 | 3.29162269 |
6 | MARK1 | 2.94757871 |
7 | MAP2K7 | 2.83013141 |
8 | TNIK | 2.71827356 |
9 | ACVR1B | 2.55983627 |
10 | ZAK | 2.46180799 |
11 | MAP3K4 | 2.40863458 |
12 | CDC7 | 2.32943225 |
13 | TRIM28 | 2.32163016 |
14 | EPHA4 | 2.29184987 |
15 | TYRO3 | 2.16802278 |
16 | PRPF4B | 2.05272031 |
17 | MAPK13 | 2.01390740 |
18 | MINK1 | 1.94421681 |
19 | PLK2 | 1.94174473 |
20 | SIK2 | 1.94147548 |
21 | PNCK | 1.93652763 |
22 | DYRK2 | 1.92675956 |
23 | MAP4K2 | 1.82239988 |
24 | SIK3 | 1.78089509 |
25 | GRK5 | 1.76004092 |
26 | NTRK2 | 1.73343355 |
27 | NEK2 | 1.72986439 |
28 | MAP2K4 | 1.68797119 |
29 | MAP3K9 | 1.67727461 |
30 | PIK3CG | 1.65944773 |
31 | PIK3CA | 1.62418102 |
32 | BMPR2 | 1.57827166 |
33 | TTK | 1.56585505 |
34 | ADRBK2 | 1.53546258 |
35 | BRSK2 | 1.49069317 |
36 | MST4 | 1.47873039 |
37 | TNK2 | 1.43458370 |
38 | PLK3 | 1.39055271 |
39 | FGR | 1.35058538 |
40 | CAMK2A | 1.31527524 |
41 | MAP3K13 | 1.29986794 |
42 | LATS2 | 1.28706331 |
43 | PRKCG | 1.28631894 |
44 | SGK2 | 1.24753333 |
45 | RIPK4 | 1.24439204 |
46 | FES | 1.21504555 |
47 | MYLK | 1.19659716 |
48 | OBSCN | 1.13873665 |
49 | DAPK2 | 1.10894455 |
50 | OXSR1 | 1.10041171 |
51 | BMX | 1.09929969 |
52 | TAF1 | 1.08533695 |
53 | PRKCE | 1.06912033 |
54 | CDK19 | 1.06864568 |
55 | STK3 | 1.05957701 |
56 | FRK | 1.05391258 |
57 | CDK5 | 1.04303483 |
58 | MAP3K14 | 1.03993597 |
59 | IRAK2 | 1.03726244 |
60 | EIF2AK2 | 1.02833953 |
61 | STK24 | 0.98813549 |
62 | DAPK1 | 0.98730626 |
63 | PTK2B | 0.98260221 |
64 | VRK1 | 0.97352084 |
65 | PLK1 | 0.96158861 |
66 | GRK7 | 0.95028453 |
67 | SGK494 | 0.94226645 |
68 | SGK223 | 0.94226645 |
69 | BMPR1B | 0.92092900 |
70 | CHEK2 | 0.86271395 |
71 | TGFBR1 | 0.85627785 |
72 | IRAK3 | 0.85241004 |
73 | NTRK1 | 0.84763813 |
74 | MKNK1 | 0.84689774 |
75 | PLK4 | 0.84462467 |
76 | DYRK3 | 0.83131715 |
77 | MUSK | 0.83019920 |
78 | IRAK1 | 0.82765409 |
79 | SGK1 | 0.81955846 |
80 | CSNK1G2 | 0.80650569 |
81 | NME1 | 0.79511311 |
82 | ERBB3 | 0.79170624 |
83 | WNK3 | 0.78631792 |
84 | KSR1 | 0.77756880 |
85 | CAMK1 | 0.77339022 |
86 | PKN1 | 0.73057567 |
87 | IRAK4 | 0.70476078 |
88 | PAK6 | 0.70095105 |
89 | TLK1 | 0.69760029 |
90 | TXK | 0.68629902 |
91 | PHKG2 | 0.67886756 |
92 | PHKG1 | 0.67886756 |
93 | BCR | 0.67835528 |
94 | ADRBK1 | 0.66035516 |
95 | CAMK2B | 0.65906811 |
96 | DYRK1A | 0.65569593 |
97 | BTK | 0.65427515 |
98 | ILK | 0.64182347 |
99 | TEC | 0.63810331 |
100 | NEK6 | 0.62543508 |
101 | SGK3 | 0.59314479 |
102 | YES1 | 0.58161911 |
103 | PAK3 | 0.57410950 |
104 | STK11 | 0.56252073 |
105 | STK38L | 0.54939467 |
106 | ATR | 0.53394831 |
107 | INSRR | 0.53164520 |
108 | ATM | 0.52966299 |
109 | CCNB1 | 0.52806314 |
110 | CAMK4 | 0.51297914 |
111 | DDR2 | 0.51071785 |
112 | PBK | 0.50954029 |
113 | VRK2 | 0.49635703 |
114 | AURKB | 0.48908650 |
115 | BCKDK | 0.48897754 |
116 | EPHA3 | 0.48436441 |
117 | FGFR2 | 0.48194774 |
118 | PRKACA | 0.46835764 |
119 | SYK | 0.46052444 |
120 | RPS6KA5 | 0.45946983 |
121 | CAMK2D | 0.45919366 |
122 | AKT3 | 0.45268633 |
123 | PINK1 | 0.44794886 |
124 | GRK1 | 0.44618604 |
125 | CAMK2G | 0.44056118 |
126 | ARAF | 0.44004773 |
127 | PRKCB | 0.43086002 |
128 | CDK8 | 0.42048514 |
129 | BLK | 0.41369372 |
130 | SRPK1 | 0.41209747 |
131 | PRKCZ | 0.40975505 |
132 | CDK3 | 0.40307140 |
133 | UHMK1 | 0.40179608 |
134 | CSNK1G3 | 0.39950998 |
135 | BRSK1 | 0.39500896 |
136 | PRKG1 | 0.39484905 |
137 | PRKCQ | 0.38907419 |
138 | FLT3 | 0.38852689 |
139 | CSNK1D | 0.38058929 |
140 | FYN | 0.38046580 |
141 | RPS6KB1 | 0.37921551 |
142 | PRKCA | 0.37785553 |
143 | PRKCH | 0.37720977 |
144 | AURKA | 0.36507112 |
145 | CSNK1A1 | 0.36369206 |
146 | CSNK1E | 0.34011183 |
147 | CAMK1G | 0.33947360 |
148 | MAP3K7 | 0.33582626 |
149 | LYN | 0.33516670 |
150 | MAPKAPK5 | 0.33222059 |
151 | WNK1 | 0.33003917 |
152 | EIF2AK1 | 0.32732216 |
153 | PRKACB | 0.27384198 |
154 | DAPK3 | 0.24921570 |
155 | CHEK1 | 0.23876220 |
156 | FGFR1 | 0.23847202 |
157 | RPS6KA3 | 0.23823514 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.78108477 |
2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.68514325 |
3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.39974436 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25013546 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.99881015 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82109075 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.74026947 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47793924 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45709909 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39117378 |
11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.33490048 |
12 | Platelet activation_Homo sapiens_hsa04611 | 2.28398020 |
13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.27870687 |
14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.20441592 |
15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19335772 |
16 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16759333 |
17 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.11311043 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06637233 |
19 | Insulin secretion_Homo sapiens_hsa04911 | 1.95104789 |
20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.92697418 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.87610079 |
22 | Ribosome_Homo sapiens_hsa03010 | 1.86282507 |
23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.83531674 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83096293 |
25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.78814318 |
26 | Salivary secretion_Homo sapiens_hsa04970 | 1.75420233 |
27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75329985 |
28 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.68971152 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66228018 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.62389293 |
31 | Long-term depression_Homo sapiens_hsa04730 | 1.62166301 |
32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.57653790 |
33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53344637 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47100599 |
35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.43680353 |
36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42448452 |
37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31991230 |
38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31937207 |
39 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.31170916 |
40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29854865 |
41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28943334 |
42 | Homologous recombination_Homo sapiens_hsa03440 | 1.27360648 |
43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.27065781 |
44 | Axon guidance_Homo sapiens_hsa04360 | 1.24644063 |
45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22177798 |
46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19789247 |
47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18829600 |
48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17583499 |
49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17377907 |
50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17328730 |
51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15960767 |
52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.15762909 |
53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.14885258 |
54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14488589 |
55 | Base excision repair_Homo sapiens_hsa03410 | 1.12244475 |
56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11988417 |
57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11889445 |
58 | Phagosome_Homo sapiens_hsa04145 | 1.08999144 |
59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08938254 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06512648 |
61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06000342 |
62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03891298 |
63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02821356 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01228001 |
65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01106392 |
66 | Phototransduction_Homo sapiens_hsa04744 | 0.97439687 |
67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95262991 |
68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95065351 |
69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94722664 |
70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93632596 |
71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92368143 |
72 | Gap junction_Homo sapiens_hsa04540 | 0.90611888 |
73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88955904 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87852509 |
75 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87354169 |
76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87186417 |
77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86351023 |
78 | Melanogenesis_Homo sapiens_hsa04916 | 0.83888699 |
79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81526838 |
80 | Cell cycle_Homo sapiens_hsa04110 | 0.80544297 |
81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78720603 |
82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.77832706 |
83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76008646 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74813745 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73878824 |
86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73626845 |
87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73341161 |
88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73194526 |
89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73145008 |
90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70994217 |
91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70633030 |
92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70459339 |
93 | RNA transport_Homo sapiens_hsa03013 | 0.68811605 |
94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68667661 |
95 | Allograft rejection_Homo sapiens_hsa05330 | 0.68373076 |
96 | Mismatch repair_Homo sapiens_hsa03430 | 0.67691474 |
97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65968048 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65640976 |
99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63745818 |
100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63294489 |
101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62846471 |
102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62715771 |
103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62679438 |
104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62099288 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61083362 |
106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58661271 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56572194 |
108 | Glioma_Homo sapiens_hsa05214 | 0.56334361 |
109 | RNA polymerase_Homo sapiens_hsa03020 | 0.54769814 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54710798 |
111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53692863 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52929879 |
113 | RNA degradation_Homo sapiens_hsa03018 | 0.52880486 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51595196 |
115 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51195031 |
116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51040889 |
117 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50398796 |
118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49451241 |
119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48496030 |
120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47499357 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47252891 |
122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46909453 |
123 | Tuberculosis_Homo sapiens_hsa05152 | 0.45771236 |
124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45665720 |
125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45247347 |
126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44271568 |
127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43931586 |
128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42675500 |
129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41881232 |
130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41170012 |
131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41111829 |
132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40312289 |
133 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40082644 |
134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39825194 |
135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39636179 |
136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39081151 |
137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38888953 |
138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38883368 |
139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38326534 |
140 | Prion diseases_Homo sapiens_hsa05020 | 0.38111872 |
141 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37810389 |
142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36439689 |
143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36145618 |
144 | Salmonella infection_Homo sapiens_hsa05132 | 0.35496189 |
145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35282985 |
146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34107773 |
147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33206854 |
148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33188317 |
149 | Alcoholism_Homo sapiens_hsa05034 | 0.31435389 |
150 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30595561 |
151 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30011170 |
152 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29135036 |
153 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28827006 |
154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28793313 |
155 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26109444 |
156 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.24631512 |
157 | Melanoma_Homo sapiens_hsa05218 | 0.24383901 |